TITLE

Inhibitors of 17�-Hydroxysteroid Dehydrogenases

AUTHOR(S)
Poirier, Donald
PUB. DATE
March 2003
SOURCE
Current Medicinal Chemistry;Mar2003, Vol. 10 Issue 6, p453
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The 17�-hydroxysteroid dehydrogenases (17�-HSDs) play an important role in the regulation of steroid hormones, such as estrogens and androgens, by catalysing the reduction of 17-ketosteroids or the oxidation of 17�-hydroxysteroids using NAD(P)H or NAD(P)+ as cofactor. The enzyme activities associated with the different 17�-HSD isoforms are widespread in human tissues, not only in classic steroidogenic tissues, such as the testis, ovary, and placenta, but also in a large series of peripheral intracrine tissues. In the nineties, several new types of 17�-HSD were reported, indicating that a fine regulation is carried out. More importantly, each type of 17�-HSD has a selective substrate affinity, directional (reductive or oxidative) activity in intact cells, and a particular tissue distribution. These findings are important for understanding the mode of action of the 17�-HSD family. From a therapeutic point of view, this means that selectivity of drug action could be achieved by targeting a particular 17�-HSD isozyme. Consequently, each study that leads to better knowledge of the inhibition of 17�-HSDs deserves attention from scientists working in this and related fields. Being involved in the last step of the biosynthesis of sex steroids from cholesterol, the 17�-HSD family constitutes an interesting target for controlling the concentration of estrogens and androgens. Thus, inhibitors of 17�-HSDs are useful tools to elucidate the role of these enzymes in particular biological systems or for a therapeutic purpose, especially to block the formation of active hydroxysteroids that stimulate estrogeno-sensitive pathologies (breast, ovarian, and endometrium cancers) and androgeno-sensitive pathologies (prostate cancer, benign prostatic hyperplasia, acne, hirsutism, etc). Few review articles have however focussed on 17�-HSD inhibitors although this family of steroidogenic enzymes includes interesting therapeutic targets for the control of several diseases. Furthermore, inhibitors of 17�-HSDs constitute a growing field in biomedical research and there is a need for an exhaustive review on this topic. In addition to giving an up-to-date description of inhibitors of all 17�-HSD isoforms (types 1-8), the present review will also address, when possible, the isoform selectivity and residual estrogenic or androgenic activity often associated with steroidal inhibitors.
ACCESSION #
11156324

 

Related Articles

  • TRANSFORMATIONS OF PROGESTERONE BY SUBCELLULAR FRACTIONS OF HUMAN SKIN. Gomez, E. C.; Frost, P.; Hsia, S. L. // Journal of Investigative Dermatology;Apr75, Vol. 64 Issue 4, p240 

    Homogenates of human skin metabolize progesterone-4-14C to the sane products as whole skin. Studies with subcellular fractions obtained by differential centrifugation indicate the presence in skin of a membrane-bound 5α-reductase and a soluble 20α-hydroxysteroid dehydrogenase (20α-HSD),...

  • Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1. Gobec, S.; Brožič, P.; Rižner, T. L. // Current Medicinal Chemistry;2008, Vol. 15 Issue 2, p137 

    Carcinogenesis of hormone-related cancers involves hormone-stimulated cell proliferation, which increases the number of cell divisions and the opportunity for random genetic errors. In target tissues, steroid hormones are interconverted between their potent, high affinity forms for their...

  • Effects of a 3{beta}-Hydroxysteroid Dehydrogenase Inhibitor, Trilostane, on the Fathead Minnow Reproductive Axis. Daniel L. Villeneuve; Lindsey S. Blake; Jeffrey D. Brodin; Jenna E. Cavallin; Elizabeth J. Durhan; Kathleen M. Jensen; Michael D. Kahl; Elizabeth A. Makynen; Dalma Martinovic; Nathaniel D. Mueller; Gerald T. Ankley // Toxicological Sciences;Jul2008, Vol. 104 Issue 1, p113 

    A number of environmental contaminants and plant flavonoid compounds have been shown to inhibit the activity of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD). Because 3β-HSD plays a critical role in steroid hormone synthesis, inhibition of 3β-HSD represents a...

  • [18F]FETO: metabolic considerations. Ettlinger, Dagmar E.; Wadsak, Wolfgang; Mien, Leonhard-Key; Machek, Michael; Wabnegger, Leila; Rendl, Gundula; Karanikas, Georgios; Viernstein, Helmut; Kletter, Kurt; Dudczak, Robert; Mitterhauser, Markus // European Journal of Nuclear Medicine & Molecular Imaging;Aug2006, Vol. 33 Issue 8, p928 

    Purpose: 11β-Hydroxylase is a key enzyme in the biosynthesis of adrenocortical steroid hormones and is a suitable target for the imaging of the adrenal cortex. [11C]Metomidate (MTO), [11C]etomidate (ETO) and desethyl-[18F]fluoroethyl-etomidate (FETO) are potent inhibitors of this enzyme and...

  • The influence of trilostane on steroid hormone metabolism in canine adrenal glands and corpora lutea-an in vitro study. Ouschan, C.; Lepschy, M.; Zeugswetter, F.; Möstl, E. // Veterinary Research Communications;Mar2012, Vol. 36 Issue 1, p35 

    Trilostane is widely used to treat hyperadrenocorticism in dogs. Trilostane competitively inhibits the enzyme 3-beta hydroxysteroid dehydrogenase (3β-HSD), which converts pregnenolone (P5) to progesterone (P4) and dehydroepiandrosterone (DHEA) to androstendione (A4). Although trilostane is...

  • In Brief.  // Nature Reviews Immunology;Jun2003, Vol. 3 Issue 6, p442 

    Tackles the findings of several studies on health-related issues. Effects of HIV infection on B-cell responses to T-cell; Role of E-protein transcription factors in B-cell activation; Influence of 3Î’-hydroxysteroid dehydrogenase on steroid hormone synthesis.

  • Steroid Hormones Related to 11β-hydroxysteroid Dehydrogenase Type 1 in Treated Obesity. MÁČOVÁ, L.; SOSVOROVÁ, L.; VÍTKŮ, J.; BIÈÍKOVÁ, M.; HILL, M.; ZAMRAZILOVÁ, H.; SEDLÁČKOVÁ, B.; STÁRKA, L. // Physiological Research;2015 Supplement2, Vol. 64, pS121 

    The local concentration of glucocorticoids is intensively regulated by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD 1). Human 11β-HSD 1 also reversibly catalyzes the inter-conversion of 7a-hydroxy- and 7β-hydroxy-dehydroepiandrosterone (DHEA) into 7-oxo-DHEA. The cohort of 282...

  • Deducing the Temporal Order of Cofactor Function in Ligand-Regulated Gene Transcription: Theory and Experimental Verification. Dougherty, Edward J.; Guo, Chunhua; Simons, Jr., S. Stoney; Chow, Carson C. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Cofactors are intimately involved in steroid-regulated gene expression. Two critical questions are (1) the steps at which cofactors exert their biological activities and (2) the nature of that activity. Here we show that a new mathematical theory of steroid hormone action can be used to deduce...

  • Roles of Steroid Sulfatase in Brain and Other Tissues. Křž, L.; Bičíková, M.; Hampl, R. // Physiological Research;2008, Vol. 57 Issue 5, p657 

    Steroid sulfatase (EC 3.1.6.2) is an important enzyme involved in steroid hormone metabolism. It catalyzes the hydrolysis of steroid sulfates into their unconjugated forms. This action rapidly changes their physiological and biochemical properties, especially in brain and neural tissue. As a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics